Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.

Timler D, Tazbir J, Matejkowska M, Gosek A, Czyz W, Brzeziński J.

Folia Histochem Cytobiol. 2001;39 Suppl 2:201-2.

PMID:
11820608
2.

Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N.

Croat Med J. 2008 Oct;49(5):643-9.

3.

Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma.

Antonaci A, Consorti F, Mardente S, Natalizi S, Giovannone G, Della Rocca C.

Oncol Rep. 2008 Jul;20(1):63-7.

PMID:
18575719
4.

Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.

Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H, Ito M, Abrosimov A, Lushnikov E, Sekine I, Yamashita Sh.

Histopathology. 2005 Sep;47(3):248-56.

PMID:
16115225
5.

Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.

Ito Y, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

Oncology. 2005;68(2-3):87-96. Epub 2005 May 9.

PMID:
15886500
6.

Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index.

Basolo F, Caligo MA, Pinchera A, Fedeli F, Baldanzi A, Miccoli P, Iacconi P, Fontanini G, Pacini F.

Thyroid. 2000 Sep;10(9):741-6.

PMID:
11041450
7.

Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.

Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK.

J Pathol. 2002 Oct;198(2):157-62.

PMID:
12237874
8.

Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.

Brzeziańska E, Cyniak-Magierska A, Sporny S, Pastuszak-Lewandoska D, Lewiński A.

Neuro Endocrinol Lett. 2007 Aug;28(4):341-50.

PMID:
17693985
9.
10.

p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Mielcarek-Kuchta D, Olofsson J, Golusinski W.

Eur Arch Otorhinolaryngol. 2003 Nov;260(10):549-54. Epub 2003 Oct 9.

PMID:
14551784
11.

Cyclin D1 expression in primary thyroid carcinomas.

Sporny S, Slowinska-Klencka D, Ratynska M.

Neuro Endocrinol Lett. 2005 Dec;26(6):815-8.

PMID:
16380680
12.

Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.

Manaios L, Tsiambas E, Alevizaki M, Karameris A, Alexopoulou D, Lambropoulou S, Moreas H, Kravvaritis C, Fotiades PP, Goula K, Patsouris E, Athanassiou AE, Koutras D, Katsilambros N.

J BUON. 2008 Oct-Dec;13(4):537-41.

PMID:
19145676
13.

Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.

Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV.

Mod Pathol. 2000 Feb;13(2):186-92.

14.

Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.

Mitselou A, Peschos D, Dallas P, Charalabopoulos K, Agnantis NJ, Vougiouklakis T.

Exp Oncol. 2004 Dec;26(4):282-6.

PMID:
15627060
15.

Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid.

Muro-Cacho CA, Holt T, Klotch D, Mora L, Livingston S, Futran N.

Otolaryngol Head Neck Surg. 1999 Feb;120(2):200-7.

PMID:
9949353
16.

The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression.

Abrosimov A, Saenko V, Meirmanov S, Nakashima M, Rogounovitch T, Shkurko O, Lushnikov E, Mitsutake N, Namba H, Yamashita S.

Endocr Pathol. 2007 Summer;18(2):68-75.

PMID:
17916995
17.

Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?

Londero SC, Godballe C, Krogdahl A, Bastholt L, Specht L, Sørensen CH, Pedersen HB, Pedersen U, Christiansen P.

Acta Oncol. 2008;47(3):451-7. Epub 2007 Sep 28.

PMID:
17906980
18.

Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.

Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, López-Arranz JS.

Oral Oncol. 2002 Apr;38(3):301-8.

PMID:
11978554
19.

Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.

Kim JY, Cho H, Rhee BD, Kim HY.

Acta Cytol. 2002 Jul-Aug;46(4):679-83.

PMID:
12146030
20.

Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma.

Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safran MS, Patwardhan NA, Khan A.

Thyroid. 2001 Dec;11(12):1101-7.

PMID:
12186496
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk